Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Phillip

Showing results (181-190 of 217) with videos related to

Pageof 22
Sort By:
Intensive Care Medicine|October 2, 2014
Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year studyMitchell M Levy, Andrew Rhodes, Gary S Phillips, et al.
Journal of Critical Care|May 18, 2012
Discordance between microcirculatory alterations and arterial pressure in patients with hemodynamic instabilityRyan C Arnold, R Phillip Dellinger, Joseph E Parrillo, et al.
Thrombosis and Haemostasis|September 8, 2004
Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebo-controlled trialWilliam D Haire, Steven R Deitcher, Kathleen M Mullane, et al.
BMJ Military Health|January 26, 2023
Changing characteristics of post-COVID-19 syndrome: Cross-sectional findings from 458 consultations using the Stanford Hall remote rehabilitation assessment toolAndrew Houston, C Tovey, K Rogers-Smith, et al.
Journal of the American College of Surgeons|April 6, 2011
Management of chronic mesenteric vascular insufficiency: an endovascular approachDenny M Schoch, Christopher J LeSar, Charles S Joels, et al.
The Journal of Infectious Diseases|July 10, 2004
Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC studyJohn C Marshall, Debra Foster, Jean-Louis Vincent, et al.
JAMA|October 11, 2018
Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical TrialR Phillip Dellinger, Sean M Bagshaw, Massimo Antonelli, et al.
Critical Care Medicine|February 22, 2013
A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsisKalpalatha Guntupalli, Nathan Dean, Peter E Morris, et al.
Journal of Clinical Medicine|December 1, 2020
Is Machine Learning a Better Way to Identify COVID-19 Patients Who Might Benefit from Hydroxychloroquine Treatment?-The IDENTIFY TrialHoyt Burdick, Carson Lam, Samson Mataraso, et al.
Computers in Biology and Medicine|August 18, 2020
Prediction of respiratory decompensation in Covid-19 patients using machine learning: The READY trialHoyt Burdick, Carson Lam, Samson Mataraso, et al.
Pageof 22

Showing results (181-190 of 217) with videos related to

Sort By:
Pageof 22
Intensive Care Medicine|October 2, 2014
Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year studyMitchell M Levy, Andrew Rhodes, Gary S Phillips, et al.
Journal of Critical Care|May 18, 2012
Discordance between microcirculatory alterations and arterial pressure in patients with hemodynamic instabilityRyan C Arnold, R Phillip Dellinger, Joseph E Parrillo, et al.
Thrombosis and Haemostasis|September 8, 2004
Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebo-controlled trialWilliam D Haire, Steven R Deitcher, Kathleen M Mullane, et al.
BMJ Military Health|January 26, 2023
Changing characteristics of post-COVID-19 syndrome: Cross-sectional findings from 458 consultations using the Stanford Hall remote rehabilitation assessment toolAndrew Houston, C Tovey, K Rogers-Smith, et al.
Journal of the American College of Surgeons|April 6, 2011
Management of chronic mesenteric vascular insufficiency: an endovascular approachDenny M Schoch, Christopher J LeSar, Charles S Joels, et al.
The Journal of Infectious Diseases|July 10, 2004
Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC studyJohn C Marshall, Debra Foster, Jean-Louis Vincent, et al.
JAMA|October 11, 2018
Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical TrialR Phillip Dellinger, Sean M Bagshaw, Massimo Antonelli, et al.
Critical Care Medicine|February 22, 2013
A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsisKalpalatha Guntupalli, Nathan Dean, Peter E Morris, et al.
Journal of Clinical Medicine|December 1, 2020
Is Machine Learning a Better Way to Identify COVID-19 Patients Who Might Benefit from Hydroxychloroquine Treatment?-The IDENTIFY TrialHoyt Burdick, Carson Lam, Samson Mataraso, et al.
Computers in Biology and Medicine|August 18, 2020
Prediction of respiratory decompensation in Covid-19 patients using machine learning: The READY trialHoyt Burdick, Carson Lam, Samson Mataraso, et al.
Pageof 22